Cited 14 times in
Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.